Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. Molecular Analysis for Precision Oncology Congress 2023

New trial designs, new paths to drug registration

Pre-clinical development of targeted agents: Change of mindset from tumour type to mechanism of action

Date

06 Oct 2023

Session

New trial designs, new paths to drug registration

Topics

Cancer Research

Tumour Site

Presenters

Elena Garralda

Authors

E. Garralda

Author affiliations

  • Early Drug Development Group, Vall d'Hebron University Hospital, 8035 - Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Christoph Benedikt Westphalen

Session: New trial designs, new paths to drug registration

Resources:

Slides

Webcast

Q&A

Presenter: Christoph Benedikt Westphalen

Session: New trial designs, new paths to drug registration

Resources:

Webcast

Q&A

Presenter: Elena Garralda

Session: New trial designs, new paths to drug registration

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.